Literature DB >> 21357707

Erythropoietin receptor is detectable on peripheral blood lymphocytes and its expression increases in activated T lymphocytes.

Katarzyna A Lisowska, Ewa Bryl, Jacek M Witkowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21357707      PMCID： PMC3046285          DOI： 10.3324/haematol.2010.038414

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.

Authors:  Katarzyna A Lisowska; Alicja Debska-Slizien; Monika Radzka; Jacek M Witkowski; Boleslaw Rutkowski; Ewa Bryl
Journal:  Artif Organs       Date:  2010-03       Impact factor: 3.094

2.  Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment.

Authors:  Katarzyna A Lisowska; Alicja Debska-Slizień; Ewa Bryl; Bolesław Rutkowski; Jacek M Witkowski
Journal:  Artif Organs       Date:  2010-05-31       Impact factor: 3.094

3.  Macrophages as novel target cells for erythropoietin.

Authors:  Lilach Lifshitz; Galit Tabak; Max Gassmann; Moshe Mittelman; Drorit Neumann
Journal:  Haematologica       Date:  2010-06-30       Impact factor: 9.941

4.  Recombinant human erythropoietin stimulates production of interleukin 2 by whole blood cell cultures of hemodialysis patients.

Authors:  E Bryl; J Myśliwska; A Debska-Slizień; P Trzonkowski; D Rachoń; B Bułło; Z Zdrojewski; A Myśliwski; B Rutkowski
Journal:  Artif Organs       Date:  1999-09       Impact factor: 3.094

5.  The polymorphonuclear leukocyte--a new target for erythropoietin.

Authors:  S Sela; R Shurtz-Swirski; R Sharon; J Manaster; J Chezar; G Shkolnik; G Shapiro; S M Shasha; S Merchav; B Kristal
Journal:  Nephron       Date:  2001-07       Impact factor: 2.847

6.  Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?

Authors:  Sara Prutchi-Sagiv; Natalia Golishevsky; Howard S Oster; Odelia Katz; Amos Cohen; Elizabeth Naparstek; Drorit Neumann; Moshe Mittelman
Journal:  Br J Haematol       Date:  2006-12       Impact factor: 6.998

7.  The influence of recombinant human erythropoietin on tumor necrosis factor alpha and interleukin-10 production by whole blood cell cultures in hemodialysis patients.

Authors:  E Bryl; J Myśliwska; A Debska-Slizień; D Rachoń; B Bułło; S Lizakowski; A Myśliwski; B Rutkowski
Journal:  Artif Organs       Date:  1998-03       Impact factor: 3.094
  7 in total
  5 in total

1.  Immunosuppressive effects of erythropoietin on human alloreactive T cells.

Authors:  Paolo Cravedi; Joaquin Manrique; Katherine E Hanlon; Jessica Reid-Adam; Joshua Brody; Praeophayom Prathuangsuk; Anita Mehrotra; Peter S Heeger
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

2.  Granulocytes Negatively Regulate Secretion of Transforming Growth Factor β1 by Bone Marrow Mononuclear Cells via Secretion of Erythropoietin Receptors in the Milieu.

Authors:  Vaijayanti Kale
Journal:  Stem Cell Rev Rep       Date:  2021-11-13       Impact factor: 6.692

3.  Erythropoietin increases macrophage-mediated T cell suppression.

Authors:  Michelle A Wood; Naomi Goldman; Kelley DePierri; John Somerville; James E Riggs
Journal:  Cell Immunol       Date:  2016-05-27       Impact factor: 4.868

4.  Novel properties of statins: suppression of the systemic and bone marrow responses induced by exposure to ambient particulate matter (PM(10)) air pollution.

Authors:  Ryohei Miyata; Ni Bai; Renaud Vincent; Don D Sin; Stephan F Van Eeden
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-13       Impact factor: 5.464

5.  A therapeutic vascular conduit to support in vivo cell-secreted therapy.

Authors:  Edward X Han; Hong Qian; Bo Jiang; Maria Figetakis; Natalia Kosyakova; George Tellides; Laura E Niklason; William G Chang
Journal:  NPJ Regen Med       Date:  2021-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.